153 related articles for article (PubMed ID: 28261298)
1. FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders.
Ozdemirkiran FG; Nalbantoglu S; Gokgoz Z; Payzin BK; Vural F; Cagirgan S; Berdeli A
Arch Med Sci; 2017 Mar; 13(2):426-432. PubMed ID: 28261298
[TBL] [Abstract][Full Text] [Related]
2. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş; Berdeli A
Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
[TBL] [Abstract][Full Text] [Related]
3. Association of FAS -670A/G and FASL -843C/T Gene Polymorphisms on Allograft Nephropathy in Pediatric Renal Transplant Patients.
Ertan P; Mir S; Ozkayin N; Berdeli A
Iran J Pediatr; 2010 Dec; 20(4):442-50. PubMed ID: 23056744
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of
Asgari R; Yari K; Mansouri K; Bakhtiari M
Biomed Rep; 2018 Apr; 8(4):391-395. PubMed ID: 29541461
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
[TBL] [Abstract][Full Text] [Related]
6. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
[TBL] [Abstract][Full Text] [Related]
7. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
8. Chronic myeloproliferative disorders.
Spivak JL; Barosi G; Tognoni G; Barbui T; Finazzi G; Marchioli R; Marchetti M
Hematology Am Soc Hematol Educ Program; 2003; ():200-24. PubMed ID: 14633783
[TBL] [Abstract][Full Text] [Related]
9. Fas/Fas Ligand pathways gene polymorphisms in pediatric renal allograft rejection.
Fadel FI; Elshamaa MF; Salah A; Nabhan M; Rasheed M; Kamel S; Kandil D; Thabet EH
Transpl Immunol; 2016 Jul; 37():28-34. PubMed ID: 27109035
[TBL] [Abstract][Full Text] [Related]
10. IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
Loureiro Dos Reis MM; Queiroz MAF; da Silva BCM; da Silva Duarte AJ; Casseb J; Arganaraz GA; Vallinoto ACR; Argañaraz ER
J Med Virol; 2020 Aug; 92(8):1148-1157. PubMed ID: 31825106
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
Sun T; Miao X; Zhang X; Tan W; Xiong P; Lin D
J Natl Cancer Inst; 2004 Jul; 96(13):1030-6. PubMed ID: 15240787
[TBL] [Abstract][Full Text] [Related]
12. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
[TBL] [Abstract][Full Text] [Related]
13. The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2008 Jan; 87(1):1-10. PubMed ID: 17938925
[TBL] [Abstract][Full Text] [Related]
14. The role of certain gene polymorphisms involved in the apoptotic pathways in polycythemia vera and essential thrombocytosis.
Dogru G; Ay OI; Erdal ME; Ay ME; Tombak A; Karakas U
Adv Clin Exp Med; 2017 Aug; 26(5):761-765. PubMed ID: 29068570
[TBL] [Abstract][Full Text] [Related]
15. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis.
Sezgin M; Barlas İÖ; Yıldır S; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
Rheumatol Int; 2013 Aug; 33(8):2039-43. PubMed ID: 23392773
[TBL] [Abstract][Full Text] [Related]
17. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (
Moawadh MS; Mir R; Tayeb FJ; Asim O; Ullah MF
Curr Issues Mol Biol; 2023 May; 45(5):3933-3952. PubMed ID: 37232720
[TBL] [Abstract][Full Text] [Related]
18. Fas, Fas Ligand, and vitamin D Receptor FokI gene polymorphisms in patients with type 1 diabetes mellitus in the Aegean region of Turkey.
Sahin SB; Cetinkalp S; Erdogan M; Yilmaz C; Berdeli A
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1179-83. PubMed ID: 22946667
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
20. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
